Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at CHF 22.6B, ahead of Eli Lilly (CHF 17.4B) and Merck & Co (CHF 15.4B). Figures as of 19 Nov 2026, 09:25 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonCHF 22.6B
- Median
- CHF 229.1M
- Combined market value
- CHF 7.66T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | CHF 108.1M | CHF 3.4B | CHF 14.36 | 2.85% down | 51% down | ||
| 102 | Ligand PharmaceuticalsLGND · Health Care | CHF 104.8M | CHF 5B | CHF 251.53 | 1.67% up | 43% up | ||
| 103 | Corcept TherapeuticsCORT · Health Care | CHF 83.9M | CHF 6.2B | CHF 57.08 | 3.25% down | 8% down | ||
| 104 | HaemoneticsHAE · Health Care | CHF 81.9M | CHF 4.7B | CHF 103.45 | 1.60% up | 61% up | ||
| 105 | Amneal PharmaceuticalsAMRX · Health Care | CHF 60.7M | CHF 6.4B | CHF 18.42 | 3.60% up | 83% up | ||
| 106 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 49.7M | CHF 6.3B | CHF 80.04 | 0.06% down | 126% up | ||
| 107 | RepligenRGEN · Health Care | CHF 41.2M | CHF 9.3B | CHF 145.40 | 6.47% up | 5% up | ||
| 108 | LifeStance Health GroupLFST · Health Care | CHF 8.1M | CHF 4.4B | CHF 11.59 | 2.82% down | 129% up | ||
| 109 | BillionToOneBLLN · Health Care | CHF 6.3M | CHF 3.7B | CHF 77.08 | 6.11% down | 0% up | ||
| 110 | Arrowhead PharmaceuticalsARWR · Health Care | -CHF 1.4M | CHF 5.1B | CHF 36.30 | 0.28% up | 10% up | ||
| 111 | BrukerBRKR · Health Care | -CHF 7.2M | CHF 8.1B | CHF 53.27 | 3.10% up | 41% up | ||
| 112 | RadNetRDNT · Health Care | -CHF 15.7M | CHF 4.8B | CHF 60.48 | 4.14% down | 7% down | ||
| 113 | Mirum PharmaceuticalsMIRM · Health Care | -CHF 19.7M | CHF 5.1B | CHF 77.88 | 0.59% up | 31% up | ||
| 114 | Travere TherapeuticsTVTX · Health Care | -CHF 21.5M | CHF 4.1B | CHF 42.30 | 1.68% down | 44% up | ||
| 115 | 10x GenomicsTXG · Health Care | -CHF 36.7M | CHF 6.3B | CHF 48.06 | 1.37% up | 260% up | ||
| 116 | Adaptive BiotechnologiesADPT · Health Care | -CHF 50.1M | CHF 3.9B | CHF 23.96 | 0.11% down | 88% up | ||
| 117 | Caris Life SciencesCAI · Health Care | -CHF 57.3M | CHF 4.7B | CHF 16.42 | 2.21% down | 17% down | ||
| 118 | VeradermicsMANE · Health Care | -CHF 58.9M | CHF 4.4B | CHF 105.14 | 0.62% down | 233% up | ||
| 119 | Belite BioBLTE · Health Care | -CHF 65.4M | CHF 5.3B | CHF 131.55 | 0.94% down | 31% up | ||
| 120 | Twist BioscienceTWST · Health Care | -CHF 65.4M | CHF 6.7B | CHF 97.97 | 3.88% up | 340% up | ||
| 121 | Oruka TherapeuticsORKA · Health Care | -CHF 88.8M | CHF 5.5B | CHF 80.62 | 0.60% down | 241% up | ||
| 122 | HeartflowHTFL · Health Care | -CHF 98.3M | CHF 3.4B | CHF 38.64 | 2.51% down | 73% up | ||
| 123 | ErascaERAS · Health Care | -CHF 104.9M | CHF 4.1B | CHF 11.59 | 0.94% down | 403% up | ||
| 124 | Protagonist TherapeuticsPTGX · Health Care | -CHF 109.6M | CHF 7B | CHF 107.07 | 2.00% up | 46% up | ||
| 125 | Charles River Laboratories InternationalCRL · Health Care | -CHF 121.5M | CHF 13.4B | CHF 280.61 | 0.33% up | 105% up | ||
| 126 | Spyre TherapeuticsSYRE · Health Care | -CHF 130.7M | CHF 8.1B | CHF 85.43 | 8.15% up | 286% up | ||
| 127 | CG OncologyCGON · Health Care | -CHF 135.6M | CHF 6B | CHF 67.36 | 1.34% up | 85% up | ||
| 128 | Dianthus TherapeuticsDNTH · Health Care | -CHF 136.7M | CHF 4B | CHF 70.71 | 3.45% down | 113% up | ||
| 129 | Edgewise TherapeuticsEWTX · Health Care | -CHF 141.3M | CHF 3.8B | CHF 34.84 | 1.59% down | 88% up | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | -CHF 154.2M | CHF 5.9B | CHF 112.83 | 1.43% down | 7% down | ||
| 131 | Definium TherapeuticsDFTX · Health Care | -CHF 154.8M | CHF 3.4B | CHF 24.52 | 0.88% down | 169% up | ||
| 132 | GlaukosGKOS · Health Care | -CHF 158M | CHF 11.6B | CHF 196.26 | 4.18% down | 152% up | ||
| 133 | Rhythm PharmaceuticalsRYTM · Health Care | -CHF 165.5M | CHF 6.9B | CHF 100.24 | 2.08% up | 13% up | ||
| 134 | NateraNTRA · Health Care | -CHF 175.3M | CHF 35.3B | CHF 243.77 | 0.71% up | 32% up | ||
| 135 | Kodiak SciencesKOD · Health Care | -CHF 193.6M | CHF 5.4B | CHF 82.36 | 1.04% up | 396% up | ||
| 136 | Elanco Animal HealthELAN · Health Care | -CHF 195.4M | CHF 11.2B | CHF 22.48 | 3.29% up | 20% up | ||
| 137 | LivaNovaLIVN · Health Care | -CHF 204.2M | CHF 4.4B | CHF 79.61 | 2.85% up | 71% up | ||
| 138 | Ascendis PharmaASND · Health Care | -CHF 213M | CHF 14.9B | CHF 227.63 | 0.32% down | 28% up | ||
| 139 | Madrigal PharmaceuticalsMDGL · Health Care | -CHF 242.7M | CHF 7.8B | CHF 335.20 | 5.67% down | 24% down | ||
| 140 | Legend BiotechLEGN · Health Care | -CHF 249.9M | CHF 2.7B | CHF 13.68 | 0.87% up | 42% down | ||
| 141 | Roivant SciencesROIV · Health Care | -CHF 252.4M | CHF 23.6B | CHF 32.61 | 0.05% up | 90% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | -CHF 255.4M | CHF 7.2B | CHF 256.98 | 0.04% up | 61% up | ||
| 143 | Kymera TherapeuticsKYMR · Health Care | -CHF 262.2M | CHF 8.7B | CHF 102.00 | 0.32% down | 87% up | ||
| 144 | Cogent BiosciencesCOGT · Health Care | -CHF 277M | CHF 4.1B | CHF 23.42 | 0.14% down | 20% down | ||
| 145 | MiniMed GroupMMED · Health Care | -CHF 280.4M | CHF 4B | CHF 14.31 | 4.44% down | 4% down | ||
| 146 | ImmunityBioIBRX · Health Care | -CHF 295.9M | CHF 6B | CHF 5.64 | 7.03% up | 193% up | ||
| 147 | Jazz PharmaceuticalsJAZZ · Health Care | -CHF 299.9M | CHF 13.4B | CHF 208.63 | 2.93% up | 37% up | ||
| 148 | Bausch + LombBLCO · Health Care | -CHF 303.1M | CHF 6.3B | CHF 17.64 | 0.58% up | 42% up | ||
| 149 | ABIVAXABVX · Health Care | -CHF 314M | CHF 6.2B | CHF 70.59 | 2.11% up | 27% down | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | -CHF 318.2M | CHF 4.9B | CHF 40.42 | 6.48% up | 14% up | ||
| 151 | Ionis PharmaceuticalsIONS · Health Care | -CHF 321.1M | CHF 3.8B | CHF 23.06 | 1.59% up | 64% down | ||
| 152 | GRAILGRAL · Health Care | -CHF 343.8M | CHF 3.9B | CHF 85.97 | 3.57% down | 20% up | ||
| 153 | Guardant HealthGH · Health Care | -CHF 350.5M | CHF 16.5B | CHF 122.21 | 1.30% up | 44% up | ||
| 154 | Oscar HealthOSCR · Health Care | -CHF 373.2M | CHF 7.2B | CHF 23.22 | 7.61% down | 112% up | ||
| 155 | ImmunovantIMVT · Health Care | -CHF 425.7M | CHF 5.8B | CHF 27.93 | 0.12% down | 43% up | ||
| 156 | AvantorAVTR · Health Care | -CHF 446.4M | CHF 8.8B | CHF 12.94 | 1.25% up | 38% up | ||
| 157 | CRISPR TherapeuticsCRSP · Health Care | -CHF 489.7M | CHF 3.3B | CHF 33.84 | 0.10% up | 21% down | ||
| 158 | BridgeBio PharmaBBIO · Health Care | -CHF 617.2M | CHF 12.8B | CHF 65.69 | 1.58% up | 17% up | ||
| 159 | VaxcytePCVX · Health Care | -CHF 645.5M | CHF 7.8B | CHF 49.28 | 1.48% down | 22% up | ||
| 160 | CytokineticsCYTK · Health Care | -CHF 661M | CHF 6B | CHF 43.21 | 0.64% down | 20% down | ||
| 161 | TeleflexTFX · Health Care | -CHF 762.6M | CHF 5.5B | CHF 139.65 | 3.95% up | 51% up | ||
| 162 | Takeda PharmaceuticalTAK · Health Care | -CHF 803.6M | CHF 57.2B | CHF 17.91 | 1.71% down | 54% up | ||
| 163 | Baxter InternationalBAX · Health Care | -CHF 805.8M | CHF 11.4B | CHF 22.03 | 1.55% up | 46% up | ||
| 164 | Summit TherapeuticsSMMT · Health Care | -CHF 909.1M | CHF 7.1B | CHF 8.84 | 1.59% down | 36% down | ||
| 165 | Revolution MedicinesRVMD · Health Care | -CHF 952.6M | CHF 29.1B | CHF 134.57 | 1.76% down | 131% up | ||
| 166 | BioNTechBNTX · Health Care | -CHF 1.1B | CHF 17.4B | CHF 70.11 | 1.89% down | 16% down | ||
| 167 | InsmedINSM · Health Care | -CHF 1.1B | CHF 22.1B | CHF 100.88 | 1.69% down | 40% down | ||
| 168 | ModernaMRNA · Health Care | -CHF 2.4B | CHF 67B | CHF 165.71 | 4.84% down | 755% up | ||
| 169 | ViatrisVTRS · Health Care | -CHF 3B | CHF 19.6B | CHF 17.08 | 0.83% down | 96% up | ||
| 170 | CenteneCNC · Health Care | -CHF 5.6B | CHF 28.1B | CHF 56.80 | 7.03% down | 102% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8420 CHF).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (CHF 22.6B), Eli Lilly (CHF 17.4B) and Merck & Co (CHF 15.4B) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 09:25 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of CHF 7.66T as of 19 Nov 2026, 09:25 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.